| Report Code: A15061 | Pages: NA | Mar 2023 | 757 Views | ||
| Author(s) : NA | Tables: NA | Charts: NA |
| |
Pandemic disrupted the entire world and affected many industries.
Get detailed COVID-19 impact analysis on the Amiodarone Hydrochloride Market
Request Now !Amiodarone (cordarone) is a type of medication, which is known as class III antiarrhythmics. It is used to treat and prevent recurrent hemodynamically, irregular heartbeats, ventricular arrhythmias such as ventricular fibrillation, ventricular tachycardia, and wide complex tachycardia, supraventricular tachycardia, atrial fibrillation, and paroxysmal. It relaxes the overactive heartbeat by slowing down the nerve activity. Amiodarone can be used for both life-threatening situation as well as a long-term suppression of arrhythmias, be it supraventricular or ventricular.
COVID-19 Impact analysis
Pharmaceutical and biotech companies together with governments around the globe are working to address the COVID-19 outbreak, from supporting the development of vaccines to planning for medicine supply chain challenges. Currently, around 115 vaccine candidates and 155 molecules are in the R&D pipeline. Moreover, commonly used drugs such as hydroxychloroquine have witnessed a dramatic surge in demand for the management of COVID-19. Such high demand for these drugs has presented huge opportunities for manufacturers of COVID-19 management drugs, as many developed countries are facing shortage of these drugs. Thus, the pharmaceutical and biotechnology industries are expected to witness a significant growth in the future, owing to the demand for vaccine and treatment drugs for COVID-19. This, in turn, is expected to have a significant impact on the amiodarone market.
Top Impacting Factors
Market Trends
New product launches to flourish the market
In 2018, Mayne Pharma Group Limited, an Australian pharma company, announced the launch of amiodarone 200mg tablets, a generic alternative to the Cordarone® tablets in the U.S.
In 2021, Piramal Pharma Limited, a pharmaceutical company, took over Hemmo Pharmaceuticals Pvt Ltd., which is a leading Indian manufacturer of Peptide APIs, to enhance product portfolio.
Key Benefits of the Report
Questions Answered in the Amiodarone Report
Amiodarone Hydrochloride Market Report Highlights
| Aspects | Details |
|---|---|
| By Drug Type |
|
| By Purity Level |
|
| By Distribution Channel |
|
| By Region |
|
| Key Market Players | Piramal Pharma Limited, Olon, Glenmark Pharma,, CTX Lifesciences,, PMC Isochem,, Zhejiang Sanmen Hengka,, United Pharma Industri,, Cambrex, Ltd,, Unichem Laboratories Limited,, Arevipharma,, Globe Quimica Ltda,, Sanofi, Shanghai Pharmaceutical Group Co. |
Loading Table Of Content...
Start reading.
This Report and over 19,601+ more Reports, Available with Avenue Library. T&C*.
Enterprise
License/PDF
Library
Membership
*Taxes/Fees, if applicable will be added during checkout. All prices in USD
To ensure high-level data integrity, accurate analysis, and impeccable forecasts
For complete satisfaction
On-demand customization of scope of the report to exactly meet your needs
Targeted market view to provide pertinent information and save time of readers
Get insights on topics that are crucial for your business. Stay abreast of your interest areas.
Get Industry Data AlertsTo ensure high-level data integrity, accurate analysis, and impeccable forecasts
For complete satisfaction
On-demand customization of scope of the report to exactly meet your needs
Targeted market view to provide pertinent information and save time of readers
Contact Details
Need to talk to an expert? Book your free consultation and let our research experts help you with your needs/problems.
